CD
TMO icon

Chapin Davis’s Thermo Fisher Scientific TMO Stock Holding History

Chapin Davis’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-351
Closed -$204K – 273
2025
Q4 		$204K Buy
+351
New +$198K 0.05% 234
2023
Q3 		– Sell
-384
Closed -$200K – 233
2023
Q2 		$200K Buy
+384
New +$207K 0.1% 197

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Chapin Davis's TMO Position: Q1 2026 in Review

Chapin Davis sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 351 shares — an estimated $204K sold.

Chapin Davis first reported a position in TMO in Q2 2023 and held it in 2 quarters. The position peaked at $204K in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Chapin Davis reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Chapin Davis sold 351 Thermo Fisher Scientific shares in Q1 2026, an estimated $204K.
  • Chapin Davis first reported a position in Thermo Fisher Scientific in Q2 2023 and held it in 2 quarters.
  • Chapin Davis's Thermo Fisher Scientific position peaked at $204K in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Chapin Davis's 13F filing for Q1 2026, filed 21 Apr 2026.